Remove Clinical Supply Remove Clinical Trials Remove Compliance Remove Gene Therapy
article thumbnail

Catalent Adds New Cryogenic Capabilities at Shiga, Japan, Facility to Support Clinical Supply Demand for Cell and Gene Therapy Development

The Pharma Data

State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational advanced therapy products by minimizing their time-out-of-environment. With sites in the U.S.,

article thumbnail

A supply chain to match the changing face of scienceĀ 

Drug Discovery World

Ten years ago, cell and gene therapy (CGT) was really finding its feet as success stories such as that of Emily Whitehead began to hit the news. In early clinical trials, a broad indication therapy may have sufficient patients and supply chain partners locally, but this changes on scale up to commercial approval.